The ZEST clinical trial, designed to evaluate niraparib (Zejula) for the prevention of breast cancer recurrence in patients ...
Researchers examined pooled data from two clinical trials that enrolled patients with low- or intermediate-grade ductal ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback